Funobactam
Funobactam[edit | edit source]
Funobactam is a novel antibiotic compound that belongs to the class of beta-lactamase inhibitors. It is primarily used in combination with other antibiotics to enhance their efficacy against resistant bacterial strains. Funobactam is particularly effective against Gram-negative bacteria, which are known for their robust resistance mechanisms.
Mechanism of Action[edit | edit source]
Funobactam works by inhibiting the activity of beta-lactamase enzymes produced by certain bacteria. These enzymes are responsible for breaking down beta-lactam antibiotics, rendering them ineffective. By inhibiting these enzymes, Funobactam allows beta-lactam antibiotics to retain their antibacterial activity, thus overcoming bacterial resistance.
Clinical Applications[edit | edit source]
Funobactam is used in combination with beta-lactam antibiotics such as penicillins and cephalosporins. This combination is particularly useful in treating infections caused by multi-drug resistant organisms, including those producing extended-spectrum beta-lactamases (ESBLs) and carbapenem-resistant Enterobacteriaceae (CRE).
Pharmacokinetics[edit | edit source]
The pharmacokinetic profile of Funobactam is characterized by its ability to achieve high concentrations in the bloodstream, which is essential for its effectiveness as a beta-lactamase inhibitor. It is typically administered intravenously, and its dosage is adjusted based on the severity of the infection and the patient's renal function.
Safety and Side Effects[edit | edit source]
Funobactam is generally well-tolerated, with a safety profile similar to other beta-lactamase inhibitors. Common side effects include nausea, diarrhea, and allergic reactions. Serious adverse effects are rare but can include anaphylaxis and seizures, particularly in patients with renal impairment.
Development and Research[edit | edit source]
Research on Funobactam is ongoing, with studies focusing on its efficacy against emerging resistant bacterial strains. It is part of a broader effort to develop new antibiotics and adjuvants to combat antibiotic resistance, a growing public health concern.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
